Christie Group plcLSE: CTG

Christie & Co publishes Pharmacy Market Review 26

· Issued by Christie Group plc

Summary by 6ix AI

Christie Group plc's agency and advisory business, Christie & Co, has published its Pharmacy Market Review 2026. The review covers the UK pharmacy market, drawing on Christie & Co's transaction and valuation data and on input from pharmacy operators across England, Scotland and Wales.

Key details

  • Christie & Co advised on, agreed or sold 1,145 pharmacies with a combined value of more than £724 million across the second half of 2025 and the first half of 2026.
  • Christie & Co completed 312 pharmacy valuation instructions in 2025, up 68% compared to 2024, and 128 in the first half of 2026.
  • Christie & Co's analysis found average pharmacy gross profit margins increased to 34.6% in the first half of 2026. EBITDA margins (earnings before interest, tax, depreciation and amortisation as a share of sales) rose from 9.2% to 11.5%. The review says recent funding uplifts supported the improved performance.
  • In Christie & Co's survey, 75% of operators said they plan to either buy or sell a pharmacy within the next three years. A further 39% named acquiring a pharmacy as a key growth opportunity.

6ix AI wrote this summary from the release below and checked it against the release.

1 October 2026

Christie Group plc

("Christie Group" or the "Company")

Christie & Co publishes Pharmacy Market Review 2026

Annual review highlights continued transaction activity and improved operator performance

Christie Group plc (CTG.L) reports that its agency and advisory business, Christie & Co, has published its Pharmacy Market Review 2026, which shares insights into the UK pharmacy market, drawing on Christie & Co's transactional and valuation activity data, alongside insights from operators across England, Scottland and Wales.

The report illustrates improving financial performance across the pharmacy sector, alongside continued transaction activity.

Building on growing momentum in recent years, Christie & Co advised on, agreed or sold 1,145 pharmacies with a combined value of more than £724 million in across H2 2025 and H1 2026, demonstrating the continued transaction activity in the sector.

Demand for valuation services in the sector also remained strong. Christie & Co completed 312 pharmacy valuation instructions in 2025, up 68% compared to 2024. These volumes have remained strong into 2026, with Christie & Co completing 128 instructions in the first half of the year.

Recent funding uplifts have also supported improved financial performance and profitability across the sector. Christie & Co's analysis found that average gross profit margins increased to 34.6% in H1 2026, while EBITDA margins rose from 9.2% to 11.5%. Pharmacies continue to improve efficiency and expand their clinical and private healthcare services.

The review also points to continued transaction appetite. Christie & Co's survey of operators indicated that three-quarters (75%) plan to either buy or sell a pharmacy within the next three years, while a further 39% identified acquiring a pharmacy as a key growth opportunity.

Christie & Co's market leading Pharmacy team provides brokerage, valuation and consultancy services across the sector. Christie Finance, Christie Insurance and Pinders offer complementary services.

The publication is available to read on www.christie.com, or can be found by following the link below:

·      Pharmacy Market Review 2026 | Christie & Co

Dan Prickett, Chief Executive of Christie Group plc, comments: "Activity across the pharmacy market remains strong, supported by improving operator profitability and continued demand from buyers. Across H2 2025 and H1 2026, Christie & Co advised on, agreed or sold 1,145 pharmacies worth more than £724 million, while demand for our valuation services also remains strong. With three-quarters of operators surveyed planning to buy or sell over the next three years, we see continued opportunities for Christie & Co, Christie Finance, Christie Insurance and Pinders to support clients across the sector as momentum continues."

Enquiries:

Christie Group plc

Dan Prickett                                                                       07885 813101

Chief Executive

Simon Hawkins                                                                 07767 354366

Chief Financial Officer

Shore Capital

Patrick Castle                                                                     020 7408 4090

Nominated Advisor and Broker

Hudson Sandler

Alex Brennan / Emily Brooker                                      020 7796 4133/[email protected]

Financial PR

Notes to Editors:

Christie Group plc, quoted on AIM, is a leading professional business services group with 32 offices across the UK and Europe, catering to its specialist markets in the healthcare, hospitality, leisure, medical, childcare & education and retail sectors.

Christie Group operates in two complementary business divisions: Professional & Financial Services (PFS) and Stock & Inventory Systems & Services (SISS). These divisions trade under the brand names: PFS - Christie & Co, Pinders, Christie Finance and Christie Insurance: SISS - Venners.

Tracing its origins back to 1896, the Group has a long-established reputation for offering valued services to client companies in agency, valuation services, investment, consultancy, project management, stock audit and inventory management. The diversity of these services provides a natural balance to the Group's core agency business.

For more information, please go to https://www.christiegroup.com/

More about our services:

https://www.christie.com/
https://www.christieinsurance.com/
https://www.christiefinance.com
https://www.pinders.co.uk

https://www.venners.com/

Christie Group plc on 6ix

Earlier from Christie

Later from Christie

All Christie news releases